-
1
-
-
39749191084
-
Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
American Heart Association Statistics Committee Stroke Statistics Subcommittee
-
Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
-
(2008)
Circulation
, vol.117
-
-
Rosamond, W.1
Flegal, K.2
Furie, K.3
Go, A.4
Greenlund, K.5
Haase, N.6
Hailpern, S.M.7
Ho, M.8
Howard, V.9
Kissela, B.10
Kittner, S.11
Lloyd-Jones, D.12
McDermott, M.13
Meigs, J.14
Moy, C.15
Nichol, G.16
O'Donnell, C.17
Roger, V.18
Sorlie, P.19
Steinberger, J.20
Thom, T.21
Wilson, M.22
Hong, Y.23
more..
-
2
-
-
17144430936
-
Reassessing treatment of acute heart failure syndromes: The ADHERE Registry
-
Gheorghiade M, Filippatos G. Reassessing treatment of acute heart failure syndromes: the ADHERE Registry. Eur Heart J 2005; 7(suppl B):B13-B19.
-
(2005)
Eur Heart J
, vol.7
, Issue.SUPPL. B
-
-
Gheorghiade, M.1
Filippatos, G.2
-
3
-
-
63849134505
-
Rehospitalizations among patients in the Medicare fee-for-service program
-
Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360:1418-1428.
-
(2009)
N Engl J Med
, vol.360
, pp. 1418-1428
-
-
Jencks, S.F.1
Williams, M.V.2
Coleman, E.A.3
-
4
-
-
39449108561
-
Contemporary trends in the pharmacological and extracorporeal management of heart failure: A nephrologic perspective
-
Kazory A, Ross EA. Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective. Circulation 2008; 117:975-983.
-
(2008)
Circulation
, vol.117
, pp. 975-983
-
-
Kazory, A.1
Ross, E.A.2
-
5
-
-
67649583708
-
Ultrafiltration for decompensated heart failure: Renal implications
-
Kazory A, Ross EA. Ultrafiltration for decompensated heart failure: renal implications. Heart 2009;95:1047-1051.
-
(2009)
Heart
, vol.95
, pp. 1047-1051
-
-
Kazory, A.1
Ross, E.A.2
-
6
-
-
84655165020
-
Emerging therapies for heart failure: Renal mechanisms and effects
-
Kazory A, Ross EA. Emerging therapies for heart failure: renal mechanisms and effects. Heart Fail Rev 2012;17:1-16.
-
(2012)
Heart Fail Rev
, vol.17
, pp. 1-16
-
-
Kazory, A.1
Ross, E.A.2
-
7
-
-
84860356840
-
Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease
-
Koch M, Haastert B, Kohnle M, Rump LC, Kelm M, Trapp R, Aker S. Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease. Eur J Heart Fail 2012;14:530-539.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 530-539
-
-
Koch, M.1
Haastert, B.2
Kohnle, M.3
Rump, L.C.4
Kelm, M.5
Trapp, R.6
Aker, S.7
-
8
-
-
84860366542
-
Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure
-
Núñez J, González M, Miñana G, Garcia-Ramón R, Sanchis J, Bod́ V, Núñez E, Puchades MJ, Palau P, Merlos P, Llàcer A, Miguel A. Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure. Eur J Heart Fail 2012;14:540-548.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 540-548
-
-
Núñez, J.1
González, M.2
Miñana, G.3
Garcia-Ramón, R.4
Sanchis, J.5
Bod́, V.6
Núñez, E.7
Puchades, M.J.8
Palau, P.9
Merlos, P.10
Llàcer, A.11
Miguel, A.12
-
9
-
-
33947713810
-
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST outcome trial
-
Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
-
Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 2007;297:1319-1331.
-
(2007)
JAMA
, vol.297
, pp. 1319-1331
-
-
Konstam, M.A.1
Gheorghiade, M.2
Burnett Jr., J.C.3
Grinfeld, L.4
Maggioni, A.P.5
Swedberg, K.6
Udelson, J.E.7
Zannad, F.8
Cook, T.9
Ouyang, J.10
Zimmer, C.11
Orlandi, C.12
-
10
-
-
58149237120
-
Sodium removal in peritoneal dialysis: The role of icodextrin and peritoneal dialysis modalities
-
Fourtounas C, Hardalias A, Dousdampanis P, Papachristopoulos B, Savidaki E, Vlachojannis JG. Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities. Adv Perit Dial 2008;24:27-31.
-
(2008)
Adv Perit Dial
, vol.24
, pp. 27-31
-
-
Fourtounas, C.1
Hardalias, A.2
Dousdampanis, P.3
Papachristopoulos, B.4
Savidaki, E.5
Vlachojannis, J.G.6
-
11
-
-
34548221922
-
Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction
-
Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, Hillege HL. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 2007;9;872-878.
-
(2007)
Eur J Heart Fail
, vol.9
, pp. 872-878
-
-
Damman, K.1
Navis, G.2
Smilde, T.D.3
Voors, A.A.4
Van Der Bij, W.5
Van Veldhuisen, D.J.6
Hillege, H.L.7
-
12
-
-
47849130010
-
Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure
-
Mullens W, Abrahams Z, Francis GS, Taylor DO, Starling RC, Tang WH. Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Cardiac Fail 2008;14:508-514.
-
(2008)
J Cardiac Fail
, vol.14
, pp. 508-514
-
-
Mullens, W.1
Abrahams, Z.2
Francis, G.S.3
Taylor, D.O.4
Starling, R.C.5
Tang, W.H.6
-
13
-
-
0041429526
-
Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States
-
Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003;64:1071-1079.
-
(2003)
Kidney Int
, vol.64
, pp. 1071-1079
-
-
Stack, A.G.1
Molony, D.A.2
Rahman, N.S.3
Dosekun, A.4
Murthy, B.5
-
14
-
-
80054762019
-
Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure
-
REIN registry
-
Sens F, Schott-Pethelaz A-M, Labeeuw M, Colin C, Villar E; REIN registry. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Kidney Int 2011;80:970-977.
-
(2011)
Kidney Int
, vol.80
, pp. 970-977
-
-
Sens, F.1
Schott-Pethelaz, A.-M.2
Labeeuw, M.3
Colin, C.4
Villar, E.5
|